Wall Street Analysts See a 152.53% Upside in Voyager Therapeutics (VYGR): Can the Stock Really Move This High?
Portfolio Pulse from
Wall Street analysts predict a potential 152.53% upside for Voyager Therapeutics (VYGR) based on average price targets. Positive earnings estimate revisions could support this optimistic outlook.
December 03, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Voyager Therapeutics (VYGR) is projected to have a 152.53% upside according to Wall Street analysts' average price targets. Positive earnings estimate revisions may support this potential increase.
The article highlights a significant potential upside for VYGR based on analysts' price targets, which is a strong indicator of positive sentiment. Additionally, the positive trend in earnings estimate revisions suggests that the company may perform well, supporting the potential for stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100